↓ Skip to main content

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

Overview of attention for article published in New England Journal of Medicine, August 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)